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Abstract 
Laser illumination of tissue results in a characteristic fluorescence emission 
spectrum whose features depend on the type of tissue, viz., healthy, adenoma or 
malignant. Hence measurement of the fluorescence is potentially a rapid and 
reliable diagnostic method. We have applied the technique to thyroid tissues and 
found that judicious normalization of the fluorescence spectrum reveals a close 
correlation between spectral shape and tissue type. Hence the pathological state of 
the tissue can be unambiguously identified from the laser-induced fluorescence 
spectrum. The method is rapid and portable and is therefore eminently suitable for 
use during operations. 
 
Most living tissue fluoresces in one way or another. The challenge is to harness the phenomenon 
in such a way that it is useful to the surgeon. Here we examine the laser-induced fluorescence of 
thyroid tissues. It turns out that the fluorescence spectra can be captured in such a way that 
unambiguous differentiation between normal (healthy), adenoma and malignant tumours can be 
made. 
Many forms of pre-cancerous changes are difficult to detect and diagnose using conventional 
techniques, which require histological examination of biopsies obtained from visible lesions, or 
random surveillance biopsies [1,2]. These techniques not only often yield ambiguous results, but 
they are also slow. What is needed is a method for diagnosis that can be used during an operation, to 
reliably identify malignant tumours, adenomas and healthy regions within a second. 
Laser-induced fluorescence spectroscopy (LIFS). Biological tissue is a turbid optical medium, in 
which light from an incident laser beam first undergoes Fresnel reflexion from the tissue surface. 
The rest of the beam is transmitted into the tissue and its fate is dominated by absorption or multiple 
scattering or both. The relation between absorption and scattering depends upon the wavelength of 
the laser radiation and the optical properties of the tissue. In the ultraviolet range the thyroid tissue is 
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a strong absorber. The primary fluorescence centres for ultraviolet radiation are native fluorophors 
such as tryptophan, collagen, elastin and NADH [3]. 
Thyroid tissue samples were obtained from 10 different individuals as solid chunks a few mm 
thick. Each sample was divided into two parts, one half going for histo-morphological examination 
and the other for the fluorescence measurements. The latter were placed in a spectroscopic quartz 
tube and illuminated with 10 ns, 337 nm pulses from a nitrogen laser at a repetition rate of 100 Hz. 
The energy per pulse was 0.04 mJ. The beam was focused into a spot 100 µm in diameter at the 
front surface of the tissue. Fluorescent emission was collected from the front surface and passed 
through the entrance slit of a DFS-452 double diffraction spectrograph/monochromator (1200 
grooves/mm). Empty tubes neither absorbed nor emitted, but showed only Fresnel reflexion. A 
UNIPAN-233  selective nanovoltmeter (working in repetitive pulse mode) was used to read the 
output from the spectrograph photomultiplier. Emission spectra were recorded from 350 to 600 nm. 
Measurements were made at several different spots on each sample. 
Examination of many samples of different types revealed that the fluorescence emission spectra 
had the following three features: a rather constant peak centred at 465 nm, a peak of variable 
intensity centred at 395 nm, and a rising background starting at about 420 nm and increasing 
towards shorter wavelengths. Figure 1 shows the fluorescence emission spectra from three different 
tissue types, normal (healthy), adenoma and malignant. The spectra have been normalized to give 
the same peak emission intensity at 465 nm. This normalization is an essential step for exploiting the 
full power of the LIFS technique. 
The key observation for making the fluorescent emission into a surgically useful diagnostic 
technique was that malignant tumours, adenomas and healthy tissue have distinctly different 
relations between the intensities of these three features. Malignant cancerous tissue is dominated by 
the rising background, and adenomas by the peak at 395 nm. 
Although very roughly speaking adenoma gives a spectrum intermediate between the spectra of 
healthy and malignant tissue, the different spectral lineshapes make it possible to unambiguously 
differentiate mixed healthy and malignant tissue from adenoma. This is made clear in Figure 2, 
which shows two samples of intermediate character. Indeed, the averaged spectra of the extreme 
forms (healthy and malignant) can be fitted as a linear combination to the mixed spectra and hence 
used to quantitatively determine the fractions of normal and malignant tissue in the sample, or, in 
effect, the pathological degree. 
LIFS is a novel optical method developed to probe the state of living cells in situ without the 
need for tissue removal. It is useful for real-time, noninvasive medical imaging starting from the 
very early stages of disease. LIFS makes it possible to distinguish between the emission of native 
fluorophors in normal and different types of abnormal human cells. The fluorescence spectrum is 
analysed to provide qualitative and quantitative information about the states of biomolecules and 
their variations across the tissue. As LIFS operates on the molecular level, it is a robust and 
powerful tool for detection of different pathologies in optically accessible organs, without being 
influenced by other properties of the tissue, such as the age of its donor. 
The rapidity of the diagnosis (within a fraction of a second) makes the technique eminently 
suited for quickly mapping the boundary between malignant and normal tissue during an operation. 
Presently the spectroscopy is being carried out in the optics laboratory using a large, cumbersome 
and expensive setup [4]; however, every component could be miniaturized and our next goal is to 
construct a small, portable unit that can be used directly in the operating theatre. We are also 
working on the generalization of the technique to all forms of cancer. 
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Featurea 
 
Interpretation 
I395 Rising backgroundb 
 
 
<< I465 
~  I465 
shoulder 
pronounced shoulder 
absent 
absent 
strongly rising towards the UV 
weakly rising towards the UV 
normal (healthy) 
adenoma 
malignant cancer 
mixed malignant and healthy 
 
 
Table 1: Diagnostic drill for thyroid cancer. Iλ represents feature intensity at wavelength λ.  
a After normalizing the 465 nm peak to unity. b Starting at about 420 nm and increasing towards 
shorter wavelengths. 
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FIGURE LEGENDS 
Figure 1. Fluorescence emission spectra from normal (healthy) (solid line), adenoma (dashed line) 
and malignant tissue (dotted line), as determined by histo-morphological examination. Each 
spectrum is a average of 2 measurements from each of 10 different samples. Spectra are scaled to 
give the same peak emission intensity at 465 nm. 
 
Figure 2. Fluorescence emission spectra from two samples of mixed character, to which linear 
combinations of the extreme forms, healthy and malignant (also shown, as black solid and black 
dotted lines respectively) were fitted. Upper solid gray curve: spectrum from 70% healthy and 30% 
cancerous; lower solid gray curve: spectrum from 55% healthy and 45% cancerous; the 
corresponding fittings are shown as dashed black lines. 
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